The Lupus Research Alliance awarded the 2026 #LupusInsightPrize to Gregory Barton, PhD, University of California, Berkeley and Howard Hughes Medical Institute and Olivia Majer, PhD, Cincinnati Children’s Hospital. The Prize recognizes Drs. Barton and Majer’s breakthrough work revealing how UNC93B1, a key regulator of the immune system’s RNA‑sensing receptor TLR7, normally keeps immune responses in check and how genetic changes in this pathway can lead to disease, pointing to new opportunities for targeted treatments.
During a session at ACR Convergence 2026 (#ACR26) moderated by Gary Koretzky, MD, PhD, Cornell University, Drs. Barton and Majer presented their seminal findings to an esteemed audience of clinicians, researchers, and members of the scientific community.
👏 Congratulations to both for your visionary leadership and contributions advancing lupus innovation.
Check out our press release to learn more: https://t.co/vUaVlqffD7
@ACRheum
🧬 Lupus Nexus is helping researchers access the data and resources they need to advance #lupus research.
At ACR Convergence 2026 (#ACR26), the LRA's Devon Kelly took the stage at the Lightning Talks Lounge to spotlight Lupus Nexus, LRA's registry, biorepository, and data exchange platform.
During the session, Devon shared how researchers can leverage Lupus Nexus to access patient data, linked biospecimens, and molecular data to support scientific discovery, as well as opportunities to get involved as the resource continues to expand.
Learn more about Lupus Nexus: https://t.co/e9Y7gfLwKH
#LupusResearch
@ACRheum
⏰ Starting soon! Join us at ACR Convergence (#ACR26) for the 2026 Lupus Insight Prize Lectureship, featuring this year’s recipients, Gregory Barton, PhD, and Olivia Majer, PhD, as they share insights from their groundbreaking research into the TLR7 pathway and its implications for #lupus.
The @LupusResearch's Lupus Insight Prize recognizes seminal discoveries that shift the understanding of lupus. Greg Barton, PhD, and Olivia Majer, PhD, will discuss their research into how regulation of innate immune-sensing pathways governs susceptibility to lupus. Find the details in ACR Convergence Today → https://t.co/fM3HkmNFd2 @UCBerkeley@CincyChildrens
Today at ACR Convergence 2026 (#ACR26), Madison Lewis of University of Toronto will present research associated with the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), focused on strengthening how patient experiences and priorities are measured in clinical trials.
Led by the Lupus ABC Patient-Reported Outcomes (PRO) Measures Working Group, this research aims to establish a novel set of patient-reported outcome measures for systemic lupus erythematosus (SLE) trials, helping ensure that outcomes meaningful to patients are reflected in clinical research.
The work includes contributions from collaborators such as Veronica Vargas Lupo, co-chair of the Lupus Voices Council, reinforcing the importance of incorporating patient perspectives into research.
📍 Abstract Session #2870: Toward Improved Patient-Centered Outcome Assessment in SLE Trials: Development of a Novel Patient Reported Outcomes Set by the Lupus Accelerating Breakthroughs Consortium PRO Measures Working Group
📅 Tuesday, November 10 | 1:15–1:30 PM ET | W311A-D
Learn more about this research and other Lupus Research Alliance presentations at #ACR26: https://t.co/0fmifFAEhN
@ACRheum #lupus #lupusresearch
📍At ACR Convergence 2026 (#ACR26), join us this afternoon at 3:30 p.m. ET for a must-see Lupus Insight Prize Lectureship exploring groundbreaking discoveries in the TLR7 pathway and what they could mean for the future of lupus research.
Moderated by Gary Koretzky, MD, PhD, the session will feature presentations from our Lupus Insight Prize recipients Greg Barton, PhD and Olivia Majer, PhD, along with a special featured lecture from Richard Furie, MD titled "The Fungus That Ate the Fly: The Journey of Toll Like Receptor Inhibition in SLE Treatment."
We hope to see you there!
#LupusResearch #LupusInsightPrize @ACRheum
This year, the Lupus Research Alliance looks forward to honoring two champions of the lupus community at our upcoming #BreakingThroughGala:
Anna R. Fisch, our Hope in Action Honoree: a retired nonprofit professional and fundraising consultant, Lupus Research Alliance Board Member, and member of the Lupus Voices Council.
Johnson and Johnson, our Industry Partner Honoree: a healthcare company advancing innovative therapies with the potential to improve outcomes for people living with lupus.
Our honorees are changemakers who believe in the power of community, compassion, and collective impact. Join us as we recognize them for their commitment to the lupus community.
RSVP today: https://t.co/P0Tv3jT0um
If you can’t attend, you can still show your support with a donation that will go directly toward lupus research programs.
🔬 Late-breaking research at ACR Convergence 2026 (#ACR26)!
Research collaborations between #LupusTherapeutics (LT), Lupus Clinical Investigators Network (LuCIN) investigators, and biopharmaceutical partners are helping advance lupus treatment development.
LT Board Co-Chair Kenneth Kalunian, MD, will present late-breaking research on afimetoran, an investigational oral TLR7/8 inhibitor being studied for systemic lupus erythematosus (SLE).
We're proud to support collaborations that help move lupus research forward.
Head to the poster hall at 10:30 AM ET to learn more.
#LupusResearch #Lupus @ACRheum
We’re onsite at ACR Convergence 2026 (#ACR26) with Albert T. Roy, President & CEO, as he shares more information about the Lupus Research Alliance's presence at the conference and the scientific developments shaping the future of #lupus research.
▶️ Watch now!
@ACRheum
Living with lupus can mean that what your body needs looks different from one day to the next. 💜
Wellness expert Tim Grae shared an important reminder: pay attention to what your body is telling you and find movement, rest, and routines that work for you.
How do you make time to listen to your body?
#Lupus #LupusAwareness #LivingWithLupus #LupusWellness
Behind every research breakthrough are scientists asking important questions. 🔬
We're excited to celebrate Lupus Insight Prize recipients Greg Barton, PhD, and Olivia Majer, PhD, at ACR Convergence 2026 (#ACR26).
Their discoveries are shedding new light on how genetic changes in the TLR7 pathway contribute to lupus, opening new possibilities for more precise, targeted therapies.
Join us at @ACRheum on November 10 as we spotlight their work during this year's Lupus Insight Prize Lectureship!
#LupusResearch #LupusInsightPrize
The 2026 @nycmarathon may be over, but we're still cheering for our LRA #TeamLifeWithoutLupus runners! 🗽💜
Together, our runners raised an incredible $113,744 for lupus research – our highest fundraising total to date for the NYC Marathon! 👏
From the miles they ran to the support they received along the way, we're so grateful to our runners and everyone who helped make this milestone possible.
Thinking about joining us for a future race? Explore upcoming opportunities to run with Team Life Without Lupus: https://t.co/MmirlZ5I6v
#LupusResearch #TCSNYCMarathon
We’re thrilled to welcome Maxwell of 103.5 KTU, “The Beat of New York,” as host of this year’s #BreakingThroughGala on Monday, Nov. 16 in NYC! 🎉
Join us for an evening of inspiring stories of resilience and hope for the lupus community.
💜 RSVP: https://t.co/CAi3v6HBA3
#Lupus #LupusResearch
As ACR Convergence 2026 (#ACR26) continues, we’re keeping you connected to the research and conversations shaping the future of #lupusresearch.
▶️ Hear from Teodora Staeva, PhD, Chief Scientific Officer of @LupusResearch on why the discoveries recognized by this year’s #LupusInsightPrize are important for the future of #lupusresearch. @ACRheum
Celebrating the next generation of #LupusResearch at ACR Convergence 2026 (#ACR26)! 🔬👏
The Lupus Research Alliance and Rheumatology Research Foundation are proud to recognize the 2026 recipients of the Empowering Lupus Research Partnership, a collaborative initiative supporting early-career scientists and junior investigators pursuing innovative research in lupus.
During the Rheumatology Research Foundation Awards Luncheon tomorrow on Nov. 9, Teodora Staeva, PhD, Chief Scientific Officer of the Lupus Research Alliance, will help recognize this year’s five award recipients:
🔬 Mehmet Hocaoglu, MD
🔬 Tristram A.J. Ryan, PhD
🔬 John P. Huizar, MD
🔬 Daniel Panyard, PhD
🔬 Kristen Young, DO, MEd
Together, their research is exploring important questions across lupus biology, diagnosis, and treatment.
Join us in congratulating this year’s recipients! 👏
@ACRheum@RheumResearch #Rheumatology
Partnership and trust are essential to building a more inclusive future for #lupus clinical trials.
At ACR Convergence 2026 (#ACR26), Caroline Donovan, MPH, Senior Director of Patient Engagement & Education, and Taylor Adjei, MPH, Manager of Patient Engagement and Health Equity, of Lupus Therapeutics, joined Salathiel Deloach for a discussion on strengthening community engagement in clinical research, with Salathiel sharing her experience living with #lupus and bringing an important patient perspective to the conversation.
The session highlighted learnings from Project CHANGE, a pilot initiative that worked alongside three U.S. communities to co-design culturally grounded strategies aimed at increasing awareness, interest and participation in #lupus clinical trials among Black communities.
Thank you to our speakers and everyone who joined the conversation!
💬 What do you think is most important for building trust and strengthening community participation in clinical research? Share your thoughts below.
@ACRheum #LupusResearch #ClinicalTrials #HealthEquity
🌟Hello from ACR Convergence 2026 (#ACR26)🌟
We’re excited for the conversations, connections and latest advances in #lupusresearch ahead.
Stop by Booth 4514-NP to meet our leaders and connect with our team.
Are you joining us at #ACR26? Let us know in the comments what you’re most looking forward to — and don’t forget to tag the Lupus Research Alliance in your posts throughout the meeting! @ACRheum